SLC30A10 and Parkinson disease: However, we observed that the proportion of individuals manifesting parkinsonism in GLB1, SLC30A10, and SLC39A14 is lower than expected under the DYT/PARK nomenclature, where dystonia and parkinsonism should generally coexist or be prominent features in approximately half or more of the patients.